2型糖尿病合并情绪障碍治疗研究进展  

Type 2 Diabetes with Mood Disorders Treatment Research Progress

作　　者：张华[1,2] 张静[2] 李晓燕[1] 刘亭[1,2] 王养维[1] 

机构地区：[1]陕西省人民医院内分泌代谢科,西安710000 [2]延安大学,陕西延安716000

出　　处：《医学综述》2017年第10期2002-2006,共5页Medical Recapitulate

摘　　要：2型糖尿病患病率高,伴发情绪障碍发病率亦高于非糖尿病人群,其情绪障碍主要以焦虑、抑郁障碍为主。糖尿病与情绪障碍间相互影响,存在一定关联,对患者生存质量造成较大影响。其治疗包括药物和非药物治疗,抗焦虑药物主要包括苯二氮卓类和非苯二氮卓类,抗抑郁药物主要包括单胺氧化酶抑制剂,单胺类神经递质再摄取抑制剂:三环类抗抑郁药、5-羟色胺-去甲肾上腺素再摄取抑制剂、选择性5-羟色胺再摄取抑制剂、选择性去甲肾上腺素再摄取抑制剂以及中草药。非药物治疗包括糖尿病知识教育、心理支持、行为干预等,但其统一与规范尚待进一步完善。The prevalence of type 2 diabetes mellitus is high, and the incidence of mood disorder, mainly including anxiety and depression, is higher than that of non-diabetics. There is a certain correlation between mood disorders and diabetes mellitus, which has a considerable impact on patients＇ quality of life. The treatments include drug and non-drug therapy, and the anti-anxiety agents mainly include benzodiazepines and non-benzodiazepines. Antidepressant drugs mainly include monoamine oxidase inhibitors, monoamine neurotransmitter reuptake inhibitors, tricyclic antidepressants, 5-serotonin norepinephrine reuptake inhibitors ,5-selective serotonin reuptake inhibitors,selective norepinephrine reuptake inhibitors and Chinese herbal medicine. Non-drug therapy includes the education of diabetes knowledge, psychological support, the intervention of behavior and so on, which need further unification and specification.

关 键 词：2型糖尿病 情绪障碍 药物治疗 非药物治疗 

分 类 号：R589.1[医药卫生—内分泌] R749[医药卫生—内科学]